These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 2967860

  • 1. Haemorheological abnormalities in arterial hypertension and their relation to cardiac hypertrophy.
    Zannad F, Voisin P, Brunotte F, Bruntz JF, Stoltz JF, Gilgenkrantz JM.
    J Hypertens; 1988 Apr; 6(4):293-7. PubMed ID: 2967860
    [Abstract] [Full Text] [Related]

  • 2. [Left ventricular hypertrophy in hypertension: functional aspects].
    Lombardo M, Zaini G, Colloca W, Belli C.
    G Ital Cardiol; 1987 Dec; 17(12):1039-44. PubMed ID: 2972580
    [Abstract] [Full Text] [Related]

  • 3. [Blood hyperviscosity syndrome in essential arterial hypertension. Characterization and clinical effects].
    Zannad F, Medeiros C, Voisin P, Bruntz JF, Stoltz F, Gilgenkrantz JM.
    Arch Mal Coeur Vaiss; 1985 Oct; 78(11):1706-9. PubMed ID: 3938244
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Chronic hemorheological effects of the calcium antagonist nilvadipine in essential hypertension.
    Tsuda Y, Satoh K, Kitadai M, Izumi Y, Takahashi T.
    Arzneimittelforschung; 1997 Aug; 47(8):900-4. PubMed ID: 9296274
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Hemorheological alterations in hypertensive patients].
    Foresto P, D'Arrigo M, Filippini F, Gallo R, Barberena L, Racca L, Valverde J, Rasia RJ.
    Medicina (B Aires); 2005 Aug; 65(2):121-5. PubMed ID: 16075805
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Haemorheological disturbances in hypertensive type 2 diabetic patients--influence of antihypertensive therapy.
    Kearney-Schwartz A, Virion JM, Stoltz JF, Drouin P, Zannad F.
    Fundam Clin Pharmacol; 2007 Aug; 21(4):387-96. PubMed ID: 17635177
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Reduction of red blood cell disaggregability during submaximal exercise: relationship with fibrinogen levels.
    Varlet-Marie E, Gaudard A, Monnier JF, Micallef JP, Mercier J, Bressolle F, Brun JF.
    Clin Hemorheol Microcirc; 2003 Aug; 28(3):139-49. PubMed ID: 12775896
    [Abstract] [Full Text] [Related]

  • 17. [Blood fluidity in essential hypertension, arterial occlusive disease and diabetic angiopathies].
    Sternitzky R, Hänsgen K, Podhaisky H.
    Z Gesamte Inn Med; 1991 Nov; 46(16):610-4. PubMed ID: 1792802
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hemorheological and hemodynamic parameters in patients with essential hypertension and their modification by alpha-1 inhibitor drug treatment.
    Toth K, Kesmarky G, Vekasi J, Nemes J, Czopf L, Kapronczay P, Halmosi R, Papp E, Juricskay I.
    Clin Hemorheol Microcirc; 1999 Nov; 21(3-4):209-16. PubMed ID: 10711745
    [Abstract] [Full Text] [Related]

  • 20. Haemorheological, platelet and endothelial indices in relation to global measures of cardiovascular risk in hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Spencer CG, Felmeden DC, Blann AD, Lip GY.
    J Intern Med; 2007 Jan; 261(1):82-90. PubMed ID: 17222171
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.